Doug Johnson
Chief Executive Officer bij Canfund Ventures Corp.
Vermogen: 751 400 $ op 30-04-2024
Profiel
Mr. Douglas B.
Johnson is a Chairman at Pathfinder Asset Management Ltd.
(Canada), a President & Chief Executive Officer at Canfund Ventures Corp.
and a President & Chief Operating Officer at Canfund VE II Management Ltd.
He is also the founder and Chief Executive Officer of Pathfinder Asset Management Ltd.
Mr. Johnson was previously employed as a Chairman by Global Gaming Technologies Corp., a Chairman by MIGENIX, Inc., a President & Chief Executive Officer by Search Minerals, Inc., and a President & Chief Executive Officer by Search Capital, Inc. He also served on the board at Gavwest Resources Ltd.
and Ridgeline Energy Services, Inc.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
IMAFLEX INC.
2.50% | 31-12-2023 | 1 300 000 ( 2.50% ) | 751 400 $ | 30-04-2024 |
Actieve functies van Doug Johnson
Bedrijven | Functie | Begin |
---|---|---|
Canfund VE II Management Ltd. | President | 02-11-2010 |
Pathfinder Asset Management Ltd. (Canada)
Pathfinder Asset Management Ltd. (Canada) Investment ManagersFinance Pathfinder Asset Management Ltd. (Pathfinder) is an independent, employee-owned investment management firm headquartered in Vancouver, Canada. The firm was founded by Douglas B. Johnson in 2010. Pathfinder manages a custom portfolio for high-net-worth investors who seek strong performance and risk-managed results. | Chief Executive Officer | 01-01-2010 |
Canfund Ventures Corp. | Chief Executive Officer | 01-01-1992 |
Eerdere bekende functies van Doug Johnson
Bedrijven | Functie | Einde |
---|---|---|
RDX TECHNOLOGIES CORPORATION | Chairman | 19-02-2013 |
SEARCH MINERALS INC. | President | 07-05-2010 |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Chairman | 24-03-2010 |
Search Capital, Inc. | President | 28-10-2008 |
Gavwest Resources Ltd. | Director/Board Member | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
GLOBAL GAMING TECHNOLOGIES CORP. | Finance |
RDX TECHNOLOGIES CORPORATION | Industrial Services |
SEARCH MINERALS INC. | Non-Energy Minerals |
Bedrijven in privébezit | 6 |
---|---|
Canfund VE II Management Ltd. | |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Health Technology |
Gavwest Resources Ltd. | Finance |
Search Capital, Inc. | Non-Energy Minerals |
Pathfinder Asset Management Ltd. (Canada)
Pathfinder Asset Management Ltd. (Canada) Investment ManagersFinance Pathfinder Asset Management Ltd. (Pathfinder) is an independent, employee-owned investment management firm headquartered in Vancouver, Canada. The firm was founded by Douglas B. Johnson in 2010. Pathfinder manages a custom portfolio for high-net-worth investors who seek strong performance and risk-managed results. | Finance |
Canfund Ventures Corp. |